Weight-Loss Drug Wegovy Also Works Against Heart Failure

August 25, 2023

(Wall Street Journal) – There is new evidence that a popular weight-loss drug can deliver health benefits beyond shedding pounds. Novo Nordisk’s anti-obesity drug Wegovy eased the symptoms of a common form of heart failure in patients who also have obesity, researchers reported Friday. The patients who took the once-weekly injection for a year reported improvements in fatigue and shortness of breath, and found they could walk longer distances, all while losing an average of 13% of their body weight. (Read More)